You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

MIRCETTE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Mircette, and when can generic versions of Mircette launch?

Mircette is a drug marketed by Teva Branded Pharm and is included in one NDA.

The generic ingredient in MIRCETTE is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

US Patents and Regulatory Information for MIRCETTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm MIRCETTE desogestrel; ethinyl estradiol TABLET;ORAL-28 020713-001 Apr 22, 1998 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MIRCETTE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm MIRCETTE desogestrel; ethinyl estradiol TABLET;ORAL-28 020713-001 Apr 22, 1998 ⤷  Try a Trial ⤷  Try a Trial
Teva Branded Pharm MIRCETTE desogestrel; ethinyl estradiol TABLET;ORAL-28 020713-001 Apr 22, 1998 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MIRCETTE

See the table below for patents covering MIRCETTE around the world.

Country Patent Number Title Estimated Expiration
Japan H03502932 ⤷  Try a Trial
European Patent Office 0397823 PROCEDE ET SYSTEME DE CONTRACEPTION (CONTRACEPTION SYSTEM AND METHOD) ⤷  Try a Trial
Finland 103951 ⤷  Try a Trial
New Zealand 231091 CONTRACEPTION SYSTEM AND METHOD COMPRISING TIMED ADMINISTRATION OF AN ESTROGEN FOLLOWED BY A PROGESTIN ⤷  Try a Trial
Australia 4497089 ⤷  Try a Trial
Australia 4497089 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.